Liver Progenitor Cells Yield Functional Hepatocytes in Response to Chronic Liver Injury in Mice von Español–Suñer, Regina, Carpentier, Rodolphe, Van Hul, Noémi, Legry, Vanessa, Achouri, Younes, Cordi, Sabine, Jacquemin, Patrick, Lemaigre, Frédéric, Leclercq, Isabelle A

Volltext

Why and How Meet n-3 PUFA Dietary Recommendations? von Molendi-Coste, Olivier, Legry, Vanessa, Leclercq, Isabelle A.

Volltext

Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models von Coulon, Stephanie, Legry, Vanessa, Heindryckx, Femke, Van Steenkiste, Christophe, Casteleyn, Christophe, Olievier, Kim, Libbrecht, Louis, Carmeliet, Peter, Jonckx, Bart, Stassen, Jean‐Marie, Van Vlierberghe, Hans, Leclercq, Isabelle, Colle, Isabelle, Geerts, Anja

Volltext

NASH-related increases in plasma bile acid levels depend on insulin resistance von Grzych, Guillaume, Chávez-Talavera, Oscar, Descat, Amandine, Thuillier, Dorothée, Verrijken, An, Kouach, Mostafa, Legry, Vanessa, Verkindt, Hélène, Raverdy, Violeta, Legendre, Benjamin, Caiazzo, Robert, Van Gaal, Luc, Goossens, Jean-Francois, Paumelle, Réjane, Francque, Sven, Pattou, François, Haas, Joel T., Tailleux, Anne, Staels, Bart

Volltext

Effect of an FTO polymorphism on fat mass, obesity, and type 2 diabetes mellitus in the French MONICA Study von Legry, Vanessa, Cottel, Dominique, Ferrières, Jean, Arveiler, Dominique, Andrieux, Nicolas, Bingham, Annie, Wagner, Aline, Ruidavets, Jean-Bernard, Ducimetière, Pierre, Amouyel, Philippe, Meirhaeghe, Aline

Volltext

Single-nucleotide Polymorphism of CD36 Locus and Obesity in European Adolescents von Bokor, Szilvia, Legry, Vanessa, Meirhaeghe, Aline, Ruiz, Jonatan R., Mauro, Beatrice, Widhalm, Kurt, Manios, Yannis, Amouyel, Philippe, Moreno, Luis A., Molnàr, Dènes, Dallongeville, Jean

Volltext

Hepatic Stellate Cells Improve Engraftment of Human Primary Hepatocytes: A Preclinical Transplantation Study in an Animal Model von Dusabineza, Ange-Clarisse, Najimi, Mustapha, Van Hul, Noémi, Legry, Vanessa, Khuu, Dung Ngoc, Van Grunsven, Leo A., Sokal, Etienne, Leclercq, Isabelle A.

Volltext

Improvement of hepatic and extrahepatic functions and anti-inflammatory effects of nitazoxanide in disease models of LPS-induced systemic inflammation and acute-on-chronic liver fa... von Legry, Vanessa, Delataille, Philippe, Malysiak, Maryse, Daix, Valérie, Debaecker, Simon, Staels, Bart, Hanf, Remy, Hum, Dean

Volltext

THU-342 - Nitazoxanide counteracts lipopolysaccharide-induced hepatic and renal transcriptomic profile changes to improve systemic inflammation and organ damage in a disease model... von Legry, Vanessa, Bobowski-Gerard, Marie, Valentin, Nicolas Stankovic, Delataille, Philippe, Daix, Valérie, Hanf, Remy, Hum, Dean, Staels, Bart

Volltext

Nitazoxanide counteracts lipopolysaccharide-induced hepatic and renal transcriptomic profile changes to improve systemic inflammation and organ damage in a disease model of acute-o... von Legry, Vanessa, Bobowski-Gerard, Marie, Valentin, Nicolas Stankovic, Delataille, Philippe, Daix, Valérie, Hanf, Remy, Hum, Dean, Staels, Bart

Volltext

WED-105 Nitazoxanide directly protects from stress-induced cell death to alleviate liver damage in preclinical models of acute-on-chronic liver failure von Bobowski-Gerard, Marie, Debaecker, Simon, Stankovic Valentin, Nicolas, Tessier, Alexia, Elkhatib, Hana, Delataille, Philippe, Hanf, Remy, Sayah Jeanne, Sakina, Hum, Dean, Legry, Vanessa, Staels, Bart

Volltext

Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and... von Solaas, Karianne, Legry, Vanessa, Retterstol, Kjetil, Berg, Paul R, Holven, Kirsten B, Ferrières, Jean, Amouyel, Philippe, Lien, Sigbjorn, Romeo, Javier, Valtueña, Jara, Widhalm, Kurt, Ruiz, Jonatan R, Dallongeville, Jean, Tonstad, Serena, Rootwelt, Helge, Halvorsen, Bente, Nenseter, Marit S, Birkeland, Kare I, Thorsby, Per M, Meirhaeghe, Aline, Nebb, Hilde I

Volltext

Tu1503 PHARMACOKINETICS AND SAFETY OF NITAZOXANIDE IN SUBJECTS WITH HEPATIC IMPAIRMENT von Harisseh, Rania, Finnegan, Beth, Thomas, Stéphane, Legry, Vanessa, Hum, Dean, Marbury, Thomas C., Perry, Robert G., Wyatt, David J., Addy, Carol

Volltext

Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects von Legry, Vanessa, Francque, Sven, Haas, Joel T, Verrijken, An, Caron, Sandrine, Chávez-Talavera, Oscar, Vallez, Emmanuelle, Vonghia, Luisa, Dirinck, Eveline, Verhaegen, Ann, Kouach, Mostafa, Lestavel, Sophie, Lefebvre, Philippe, Van Gaal, Luc, Tailleux, Anne, Paumelle, Réjane, Staels, Bart

Volltext

Hepatic PPARα is critical in the metabolic adaptation to sepsis von Paumelle, Réjane, Haas, Joel T., Hennuyer, Nathalie, Baugé, Eric, Deleye, Yann, Mesotten, Dieter, Langouche, Lies, Vanhoutte, Jonathan, Cudejko, Céline, Wouters, Kristiaan, Hannou, Sarah Anissa, Legry, Vanessa, Lancel, Steve, Lalloyer, Fanny, Polizzi, Arnaud, Smati, Sarra, Gourdy, Pierre, Vallez, Emmanuelle, Bouchaert, Emmanuel, Derudas, Bruno, Dehondt, Hélène, Gheeraert, Céline, Fleury, Sébastien, Tailleux, Anne, Montagner, Alexandra, Wahli, Walter, Van Den Berghe, Greet, Guillou, Hervé, Dombrowicz, David, Staels, Bart

Volltext

1817-P: Elafibranor and Glucagon-Like Peptide-1 Receptor Agonists Synergize to Attenuate Hepatic Inflammation and Fibrosis in a Rodent Model of Obesity, Insulin Resistance, and NAS... von LEGRY, VANESSA, DESCAMPS, EMELINE, DEBAECKER, SIMON, STANKOVIC-VALENTIN, NICOLAS, PARROCHE, PEGGY, DEGALLAIX, NATHALIE, POULAIN, PHILIPPE, STAELS, BART, WALCZAK, ROBERT

Volltext

CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway von Deleye, Yann, Cotte, Alexia Karen, Hannou, Sarah Anissa, Hennuyer, Nathalie, Bernard, Lucie, Derudas, Bruno, Caron, Sandrine, Legry, Vanessa, Vallez, Emmanuelle, Dorchies, Emilie, Martin, Nathalie, Lancel, Steve, Annicotte, Jean Sébastien, Bantubungi, Kadiombo, Pourtier, Albin, Raverdy, Violeta, Pattou, François, Lefebvre, Philippe, Abbadie, Corinne, Staels, Bart, Haas, Joel T., Paumelle, Réjane

Volltext

AS014 - The combination of elafibranor and semaglutide drastically improves fibrosing steatohepatitis and distinctly modulates liver inflammatory signature von Legry, Vanessa, Poulain, Philippe, Valentin, Nicolas Stankovic, Parroche, Peggy, Descamps, Emeline, Belanger, Carole, Hum, Dean, Staels, Bart, Harrison, Stephen, Loomba, Rohit, Sanyal, Arun, Ratziu, Vlad, Walczak, Robert

Volltext

The combination of elafibranor and semaglutide drastically improves fibrosing steatohepatitis and distinctly modulates liver inflammatory signature von Legry, Vanessa, Poulain, Philippe, Valentin, Nicolas Stankovic, Parroche, Peggy, Descamps, Emeline, Belanger, Carole, Hum, Dean, Staels, Bart, Harrison, Stephen, Loomba, Rohit, Sanyal, Arun, Ratziu, Vlad, Walczak, Robert

Volltext

CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway von Deleye, Yann, Karen Cotte, Alexia, Hannou, Sarah Anissa, Hennuyer, Nathalie, Bernard, Lucie, Derudas, Bruno, Caron, Sandrine, Legry, Vanessa, Vallez, Emmanuelle, Dorchies, Emilie, Martin, Nathalie, Lancel, Steve S., Annicotte, Jean Sébastien, Bantubungi, Kadiombo, Pourtier, Albin, Raverdy, Violeta, Pattou, François, Lefebvre, Philippe, Abbadie, Corinne, Staels, Bart, Haas, Joel T, Paumelle, Réjane

Volltext